Trials / Completed
CompletedNCT00226343
Depakote-ER for Depressive and Bipolar Depression
Phase 4 Study: Double-blind Placebo-controlled Trial of Depakote-ER for Depressive and Anxiety Symptoms in Non-refractory Bipolar Depression
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 25 (planned)
- Sponsor
- Cambridge Health Alliance · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Obtain information using a randomized treatment to assess the antidepressant and anxiolytic efficacy of divalproex vs. placebo for nonrefractory bipolar patients with major depressive episodes.
Detailed description
Study is 6 weeks long, with 7 clinical visits.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Depakote-ER |
Timeline
- Start date
- 2003-08-01
- Primary completion
- 2006-01-01
- Completion
- 2006-08-01
- First posted
- 2005-09-27
- Last updated
- 2017-04-18
Source: ClinicalTrials.gov record NCT00226343. Inclusion in this directory is not an endorsement.